These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2467134)

  • 21. Clinical evaluation of amlodipine, a new long-acting calcium antagonist, in mild and moderate hypertension.
    Escudero J; Hernandez H
    Int J Clin Pharmacol Res; 1991; 11(5):243-6. PubMed ID: 1839989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term open evaluation of amlodipine versus hydrochlorothiazide in patients with essential hypertension.
    Rofman BA
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S94-7. PubMed ID: 2467139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of pedal edema during treatment with S(-)-amlodipine nicotinate versus amlodipine besylate in female Korean patients with mild to moderate hypertension: a 12-week, multicenter, randomized, double-blind, active-controlled, phase IV clinical trial.
    Oh GC; Lee HY; Kang HJ; Zo JH; Choi DJ; Oh BH
    Clin Ther; 2012 Sep; 34(9):1940-7. PubMed ID: 22925988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of the calcium antagonist amlodipine on blood pressure and platelet aggregation in hypertensive patients.
    Hernández R; Carvajal AR; Armas-de Hernández MJ; Guerrero-Pajuelo J; Armas-Padilla MC; Barragán O; Machado-de Alvarado I
    Postgrad Med J; 1991; 67 Suppl 5():S38-40. PubMed ID: 1839438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial.
    Hong SJ; Ahn TH; Baek SH; Cho WH; Jeon HK; Kwan J; Yoon MH; Lee KJ; Lim DS
    Clin Ther; 2006 Apr; 28(4):537-51. PubMed ID: 16750465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amlodipine versus atenolol in essential hypertension.
    Frishman WH; Brobyn R; Brown RD; Johnson BF; Reeves RL; Wombolt DG
    Am J Cardiol; 1994 Jan; 73(3):50A-54A. PubMed ID: 8310977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension.
    Dingemanse J; Otasevic P; Shakeri-Nejad K; Klainman E; Putnikovic B; Kracker H; Mueller MS; Zimlichman R
    J Hum Hypertens; 2015 Apr; 29(4):229-35. PubMed ID: 25231512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.
    Massie BM; Lacourcière Y; Viskoper R; Woittiez A; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):27C-33C. PubMed ID: 9286851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G;
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
    Messerli FH; Oparil S; Feng Z
    Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release.
    Mounier-Vehier C; Bernaud C; Carré A; Lequeuche B; Hotton JM; Charpentier JC
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):478-86. PubMed ID: 9607387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-step treatment of mild to moderate uncomplicated essential hypertension by a new calcium antagonist: nicardipine.
    Bellet M; Loria Y; Lallemand A
    J Cardiovasc Pharmacol; 1985; 7(6):1149-53. PubMed ID: 2418302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition.
    Abernethy DR; Gutkowska J; Winterbottom LM
    Clin Pharmacol Ther; 1990 Jul; 48(1):76-86. PubMed ID: 2142447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P; White W; Digranes O; Helland B; Jordal O; Stray T
    J Hypertens; 1990 Dec; 8(12):1129-36. PubMed ID: 1962802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of amlodipine in patients with mild-to-moderate hypertension.
    Olvera R; Samaniego V; Moguel R; Meaney E
    Int J Clin Pharmacol Res; 1991; 11(5):237-41. PubMed ID: 1839988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Phase III, double-blind, parallel-group controlled study of amlodipine 10 mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5 mg once daily.
    Fujiwara T; Ii Y; Hatsuzawa J; Murase H; Watanabe T; Murakami M; Kimura N; Buch J; Tsuchihashi T; Saruta T
    J Hum Hypertens; 2009 Aug; 23(8):521-9. PubMed ID: 19148107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension.
    Johnson BF; Frishman WH; Brobyn R; Brown RD; Reeves RL; Wombolt DG
    Am J Hypertens; 1992 Oct; 5(10):727-32. PubMed ID: 1418836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 24-hour blood pressure control with the once-daily calcium antagonist amlodipine.
    Raftery EB; Heber ME; Brigden G; Al-Khawaja I
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S8-12. PubMed ID: 16296698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amlodipine compared to nitrendipine in hypertensive patients: the effects on toleration in relationship to the onset of action.
    Waeber B; Borges ET; Christeler P; Guillaume-Gentil M; Hollenstein U; Mannhart M
    Cardiology; 1992; 80 Suppl 1():46-53. PubMed ID: 1534715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.